SCHEMBL8610384

SCHEMBL8610384

CCOC(=O)Cn1c(=O)c(=O)[nH]c2cc([N+](=O)[O-])c(-n3ccc(C=O)c3)cc21

nearest known ligand 0.79

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
GRIA1 P42261 8/20 0.79
GRIA2 P42262 8/20 0.79
GRIA3 P42263 8/20 0.79
GRIA4 P48058 8/20 0.79
GRIK1 P39086 8/20 0.63
GRIK2 Q13002 8/20 0.63
GRIK5 Q16478 7/20 0.63
GRIK3 Q13003 7/20 0.63
GRIK4 Q16099 4/20 0.63
SLC22A6 Q4U2R8 1/20 0.52
SLC22A8 Q8TCC7 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8681277 0.88 GRIA1 (0.76) GRIA1GRIA2GRIA3GRIA4GRIK1
SCHEMBL7666995 0.88 GRIA1 (1.00) GRIA1GRIA2GRIA3GRIA4GRIK1
SCHEMBL8610087 0.86 GRIK1 (0.82) GRIA1GRIA2GRIA3GRIA4GRIK1
SCHEMBL8676650 0.84 GRIA1 (0.73) GRIA1GRIA2GRIA3GRIA4GRIK1
Sulfuric Acid SCHEMBL7484848 0.84 GRIA1 (0.73) GRIA1GRIA2GRIA3GRIA4GRIK1
SCHEMBL8611636 0.84 GRIA1 (0.56) GRIA1GRIA2GRIA3GRIA4GRIK1
SCHEMBL9059846 0.84 GRIA1 (0.72) GRIA1GRIA2GRIA3GRIA4GRIK1
SCHEMBL7668608 0.83 GRIA1 (0.78) GRIA1GRIA2GRIA3GRIA4GRIK1
SCHEMBL8791928 0.83 GRIA1 (0.69) GRIA1GRIA2GRIA3GRIA4GRIK1
SCHEMBL7480410 0.83 GRIK1 (0.80) GRIA1GRIA2GRIA3GRIA4GRIK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5852017-A 2,3(1H,4H)-quinoxalinediones BASF AKTIENGESELLSCHAFT (DE) 1998-12-22 US disclosed
US-5849743-A Quinoxalines and drugs prepared therefrom BASF AKTIENGESELLSCHAFT (DE) 1998-12-15 US disclosed
EP-0572852-B1 Quinoxalin-2,3(1H,4H)-diones used as medicine BASF AG (DE) 1998-10-21 EP disclosed
US-5714489-A 2,3(1H,4H)quinoxalinedione BASF AKTIENGESELLSCHAFT (DE) 1998-02-03 US disclosed
WO-1996019476-A1 NOVEL QUINOXALINES AND DRUGS PREPARED THEREFROM BASF AKTIENGESELLSCHAFT (DE) 1996-06-27 WO disclosed
EP-0572852-A1 Quinoxalin-2,3(1H,4H)-diones used as medicine BASF Aktiengesellschaft (DE) 1993-12-08 EP disclosed